Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 135 for “"Ceftazidime"”.

  1. Mechanisms of IFN-γ and ceftazidime interaction for synergistic killing of Burkholderia

    … with the conventionally administered antibiotic, ceftazidime, to synergistically control intracellular bacteria burden of Burkholderia infected macrophages. The goal of the studies presented here was to determine the mechanism by which IFN-γ and ceftazidime exert their synergistic effect. After …

    colostate Repository record for Mechanisms of IFN-γ and ceftazidime interaction for synergistic killing of Burkholderia (opens in a new tab)

  2. Synthetic Data–Driven Early Prediction Framework for Acute Kidney Injury in Patients Receiving Vancomycin and Ceftazidime/Avibactam

    Background: The nephrotoxic risks of combining ceftazidime/avibactam (AVI) with vancomycin (VAN) remain underexplored, despite both agents independently being linked to acute kidney injury (AKI). This study assessed the risk of AKI associated with concurrent VAN and ceftazidime/avibactam (VAN-AVI) …

    wvu Repository record for Synthetic Data–Driven Early Prediction Framework for Acute Kidney Injury in Patients Receiving Vancomycin and Ceftazidime/Avibactam (opens in a new tab)

  3. Use of immunotherapy to enhance the efficacy of ceftazidime for the treatment of acute pulmonary Burholderia pseudomallei infection

    … cytokine production, combined with ceftazidime antimicrobial therapy elicited synergistic inhibition of intracellular B. pseudomallei replication in infected alveolar macrophages and protected mice from acutely lethal i.n. challenge with B. pseudomallei. Mice treated with CLDC and …

    colostate Repository record for Use of immunotherapy to enhance the efficacy of ceftazidime for the treatment of acute pulmonary Burholderia pseudomallei infection (opens in a new tab)

  4. ΕΠΙΔΡΑΣΗ ΤΗΣ ΑΚΕΤΑΖΟΛΑΜΙΔΗΣ ΣΤΗ ΦΑΡΜΑΚΟΚΙΝΗΤΙΚΗ ΤΗΣ ΚΕΦΤΑΖΙΝΤΙΜΗΣ ΚΑΙ ΤΗΣ ΣΙΠΡΟΦΛΟΞΑΣΙΝΗΣ ΣΤΟ ΥΔΑΤΟΕΙΔΕΣ ΥΓΡΟ ΤΟΥ ΟΦΘΑΛΜΟΥ

    … AND CEPHALOSPORIN, THE CIPROFLOXACINE AND THE CEFTAZIDIME, WITH THE ACETAZOLAMIDE INTO THE AQUEOUS HUMOR OF THE HUMAN EYE. IN CONCLUSION ACETAZOLAMIDE INCREASES SIGNIFICANTLY CEFTAZIDIME AQUEOUS HUMOR LEVELS. THE RATIOS OF AQUEOUS HUMOR TO SERUM LEVELS AFTER THE ADMINISTRATION OF CEFTAZIDIME …

    greece Repository record for ΕΠΙΔΡΑΣΗ ΤΗΣ ΑΚΕΤΑΖΟΛΑΜΙΔΗΣ ΣΤΗ ΦΑΡΜΑΚΟΚΙΝΗΤΙΚΗ ΤΗΣ ΚΕΦΤΑΖΙΝΤΙΜΗΣ ΚΑΙ ΤΗΣ ΣΙΠΡΟΦΛΟΞΑΣΙΝΗΣ ΣΤΟ ΥΔΑΤΟΕΙΔΕΣ ΥΓΡΟ ΤΟΥ ΟΦΘΑΛΜΟΥ (opens in a new tab)

  5. Mechanisms of LasR and FusA1-regulated antibiotic resistance in the bacterial pathogen Pseudomonas aeruginosa

    … their specific interactions in tobramycin and ceftazidime resistance. Typically, lasR mutants are more susceptible to tobramycin, yet are frequently isolated from chronic infections, prompting the question of how lasR mutants can emerge under antibiotic selection. Here, we show that P. …

    ku Repository record for Mechanisms of LasR and FusA1-regulated antibiotic resistance in the bacterial pathogen Pseudomonas aeruginosa (opens in a new tab)

  6. Mobilome and antibiotic resistance in Acinetobacter baumannii

    … world. Third-generation cephalosporins (such as ceftazidime) and carbapenems (such as imipenem and meropenem) represent important treatment options for infections caused by this microorganism. Nevertheless, the number of strains resistant to these antibiotics has been increasing during the last …

    edinburgh Repository record for Mobilome and antibiotic resistance in Acinetobacter baumannii (opens in a new tab)

  7. Adding insult to injury: mechanistic basis for how AmpC mutations allow Pseudomonas aeruginosa to accelerate cephalosporin hydrolysis and evade avibactam

    … (BLI) combinations ceftolozane/tazobactam and ceftazidime/avibactam. The objective of this thesis was to investigate the enzymatic activity of four of these reported AmpC mutants, E247K, G183D, T96I, and ∆G229–E247 (alongside wild-type (WT) AmpC from P. aeruginosa PAO1), to gain detailed …

    manitoba Repository record for Adding insult to injury: mechanistic basis for how AmpC mutations allow Pseudomonas aeruginosa to accelerate cephalosporin hydrolysis and evade avibactam (opens in a new tab)

  8. The efficacy of last-line and experimental antimicrobials against Stenotrophomonas maltophilia and the characterisation of resistant mutant

    … to identify novel mechanisms of resistance to ceftazidime, amikacin, levofloxacin, and minocycline. Overexpression of the chromosomally encoded serine-β-lactamase (SBL), L2, and metallo- β-lactamase (MBL), L1, is known to confer resistance to β lactams, including ceftazidime. However, the …

    bristol Repository record for The efficacy of last-line and experimental antimicrobials against Stenotrophomonas maltophilia and the characterisation of resistant mutant (opens in a new tab) Download PDF for The efficacy of last-line and experimental antimicrobials against Stenotrophomonas maltophilia and the characterisation of resistant mutant (opens in a new tab)

  9. Immune response modulation using Tolfenamic acid as an effective therapeutic for Burkholderia pseudomallei infection

    … and compared these results to effective Ceftazidime treatments and the co-treatment of TA with a sub-therapeutic treatment of Ceftazidime in BALB/c mice. TA effectively increased cell viability in vitro and was able to reduce COX-2 expression and PGE2 production while also decreasing …

    colostate Repository record for Immune response modulation using Tolfenamic acid as an effective therapeutic for Burkholderia pseudomallei infection (opens in a new tab)

  10. Antimicrobial Nanoparticles: A Green and Novel Approach for Enhancing Bactericidal Efficacy of Commercial Antibiotics

    … capping ability of a cephalosporin antibiotic, ceftazidime. No signs of aggregation or leaching of ceftazidime from GNP surface was observed upon its storage. Antibacterial testing showed dosedependent broad spectrum activity of Cef-GNPs against both Gram-positive (S. bovis and E. durans) and …

    wku-diss Repository record for Antimicrobial Nanoparticles: A Green and Novel Approach for Enhancing Bactericidal Efficacy of Commercial Antibiotics (opens in a new tab)

  11. In vitro δραστικότητα των συνδυασμών β-λακταμικών αντιμικροβιακών με τις νεώτερες φθοριοκινολόνες επί πολυανθεκτικών στελεχών Pseudomonas aeruginosa

    … exposed over time to imipenem, meropenem and ceftazidime as well as to their combinations with ciprofloxacin and moxifloxacin. All isolates were resistant to all agents tested at concentrations equal to their average serum level. Measurements: Synergy of any of the tested combinations was …

    greece Repository record for In vitro δραστικότητα των συνδυασμών β-λακταμικών αντιμικροβιακών με τις νεώτερες φθοριοκινολόνες επί πολυανθεκτικών στελεχών Pseudomonas aeruginosa (opens in a new tab)

  12. Characterisation of β-lactam/Vaborbactam activity in Klebsiella pneumoniae

    … combinations: meropenem/vaborbactam and ceftazidime/avibactam has revolutionised the management of cephalosporin and carbapenem resistant K. pneumoniae infections. With an increasing clinical dependence on these combination therapies, there is a need to study resistance mechanisms to …

    bristol Repository record for Characterisation of β-lactam/Vaborbactam activity in Klebsiella pneumoniae (opens in a new tab) Download PDF for Characterisation of β-lactam/Vaborbactam activity in Klebsiella pneumoniae (opens in a new tab)

  13. Characterisation of Antibiotic Resistance in Clostridium difficile

    … identification of genes that are responsible for ceftazidime, cefoxitin and ciprofloxacin resistance. A total of 6,000 transposon mutants were screened for resistance to each antibiotic. Three genes with defects in resistance to these antibiotics were chosen for detailed analysis. SpoVE, a …

    whiterose Download PDF for Characterisation of Antibiotic Resistance in Clostridium difficile (opens in a new tab)

  14. Επιδημιολογία και παράγοντες κινδύνου για αποικισμό ασθενών από εντερόκοκκο ανθεκτικό στη βανκομυκίνη σε ένα τριτοβάθμιο αντικαρκινικό κέντρο

    … demonstrated an association between exposure to ceftazidime and colonization by VRE, the treatment strategy of neutropenic fever was modified to reduce patients’ exposure to ceftazidime. The ceftazidime was substituted by piperacillin-tazobactam as the antibiotic of choice for the treatment of …

    greece Repository record for Επιδημιολογία και παράγοντες κινδύνου για αποικισμό ασθενών από εντερόκοκκο ανθεκτικό στη βανκομυκίνη σε ένα τριτοβάθμιο αντικαρκινικό κέντρο (opens in a new tab)

  15. Collateral sensitivity and the evolution of drug resistance in Escherichia coli

    … reduce the frequency of mutation to resistance. Ceftazidime resistant strains showed susceptibility to chloramphenicol. It was therefore expected that growth in sub-MIC concentrations of chloramphenicol would reduce mutation rate to ceftazidime resistance, however, an increase in mutation rate …

    carleton Repository record for Collateral sensitivity and the evolution of drug resistance in Escherichia coli (opens in a new tab)

  16. Μηχανισμοί διεύρυνσης του φάσματος υποστρωμάτων των β- λακταμασών μοριακών τάξεων Α και C

    … molecular dynamics simulations of free enzymes, ceftazidime and cefoxitin acyl-enzymes as well as of complexes with the boronoc acid analogue of ceftazidime. In GES enzymes Gly170Asn and Gly170Ser increased the hydrolytic efficiency towards carbapenems while enzymes with serine were also active …

    greece Repository record for Μηχανισμοί διεύρυνσης του φάσματος υποστρωμάτων των β- λακταμασών μοριακών τάξεων Α και C (opens in a new tab)

  17. Systems Pharmacology Approaches to Describe and Exploit the Pathways to Polymyxin and β-lactam Resistance in Metallo-β-lactamase-producing Gram Negatives

    … the use of aztreonam in combination with ceftazidime/avibactam would revitalize aztreonam activity through inhibition of ESBLs by avibactam. In order to provide guidance on the utilization of this combination, this dissertation focused on converting literature-based population …

    buffalo Repository record for Systems Pharmacology Approaches to Describe and Exploit the Pathways to Polymyxin and β-lactam Resistance in Metallo-β-lactamase-producing Gram Negatives (opens in a new tab)

  18. Development of polymyxin and aminoglycoside-based outer membrane permeabilizing antibiotic potentiators

    … of potentiating rifampicin, erythromycin, ceftazidime and aztreonam against multidrug-resistant Gram-negative bacteria; (2) guanidinylated amphiphilic tobramycin derivatives which enhanced ceftazidime and aztreonam, and their combinations with avibactam against β-lactamase harboring …

    manitoba Repository record for Development of polymyxin and aminoglycoside-based outer membrane permeabilizing antibiotic potentiators (opens in a new tab)

Page 1 of 7